Skip to search formSkip to main contentSkip to account menu

Chronic Graft Versus Host Disease

Known as: Chronic GVHD, GVHD, chronic, Graft versus host disease, chronic 
A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with… 
National Institutes of Health

Related topics

Related topics

2 relations
Immune System DiseasesImmunologic Deficiency Syndromes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Chronic graft-versus-host disease
Purpose of review Chronic graft-versus-host disease is an important cause of late morbidity and mortality after allogeneic stem… 
Highly Cited
2005
Highly Cited
2005
Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells.
4-1BB, a member of the tumor necrosis factor (TNF) receptor superfamily, is a costimulator for activated T cells. Previous… 
Review
2004
Review
2004
Diagnosis and clinical management of chronic graft-versus-host disease
Chronic graft-versus-host disease (GVHD) occurs in approximately 60% of patients who survive for more than 100 days after… 
Highly Cited
2002
Highly Cited
2002
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem…
Highly Cited
2001
Highly Cited
2001
The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients.
The oral manifestations of chronic graft-versus-host disease (cGVHD) in eight allogeneic bone marrow transplant (BMT) paediatric… 
Highly Cited
1996
Highly Cited
1996
Specificity of antinuclear antibodies in scleroderma‐like chronic graft‐versus‐host disease: clinical correlation and histocompatibility locus antigen association
Summary Chronic graft‐versus‐host disease after bone marrow transplantation presents, in a few cases, as mild to severe… 
Highly Cited
1990
Highly Cited
1990
In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment
Previous work from this laboratory has demonstrated that T cell- depleted (TCD) syngeneic marrow can delay, but not prevent, the… 
Highly Cited
1988
Highly Cited
1988
Renal involvement in chronic graft-versus-host disease: a report of two cases.
We report details of renal involvement during the course of chronic graft-versus-host disease (cGVHD) in two patients undergoing… 
1979
1979
The ultrastructure of the human epidermis in chronic graft-versus-host disease.
The epidermal ultrastructure of 11 allogeneic bone marrow recipients with chronic graft-versus-host disease (GVHD) was compared… 
Highly Cited
1973
Highly Cited
1973
Autoimmunity in chronic graft-versus-host disease.
F1 mice with chronic GVH disease were studied to investigate the hypothesis that non-specific stimulation of helper T cells, such… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)